Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 1.4M | $4.7M | 0% | Dec 2024 |
|
| Eventide Asset Management | 1.4M | $4.4M | 0% | Dec 2024 |
|
| Citadel Advisors | 1.2M | $4.1M | 4% | Dec 2024 |
|
| Vanguard Group | 475k | $1.6M | 7% | Dec 2024 |
|
| Palo Alto Investors | 445k | $1.5M | 0% | Dec 2024 |
|
| Exome Asset Management | 353k | $1.2M | 0% | Dec 2024 |
|
| UBS O'Connor | 246k | $823k | 100% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 177k | $592k | 5% | Dec 2024 |
|
| Adage Capital Partners GP | 154k | $516k | 100% | Dec 2024 |
|
| Parkman Healthcare Partners | 153k | $513k | -25% | Dec 2024 |
|
| Geode Capital Management | 135k | $452k | 0% | Dec 2024 |
|
| BlackRock | 83k | $279k | 0% | Dec 2024 |
|
| Susquehanna International | 71k | $237k | 17% | Dec 2024 |
|
| Springbok Capital Management | 59k | $199k | -9% | Dec 2024 |
|
| Bridgeway Capital Management | 37k | $124k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 25k | $84k | 934% | Dec 2024 |
|
| Renaissance Technologies | 25k | $84k | -71% | Dec 2024 |
|
| Northern Trust | 24k | $80k | -36% | Dec 2024 |
|
| XTX Topco | 21k | $70k | 100% | Dec 2024 |
|
| Jane Street | 20k | $68k | 100% | Dec 2024 |
|
| Commonwealth Equity Services | 18k | $61k | 0% | Dec 2024 |
|
| State Street Corporation | 16k | $53k | 0% | Dec 2024 |
|
| Morgan Stanley | 4.3k | $14k | 139% | Dec 2024 |
|
| BFSG | 3.5k | $12k | 100% | Dec 2024 |
|
| Bank of America Corporation | 1.5k | $5.0k | -35% | Dec 2024 |
|
| Tower Research Capital | 1.4k | $4.6k | -37% | Dec 2024 |
|
| UBS Group | 631.00 | $2.1k | 4407% | Dec 2024 |
|
| CWM | 500.00 | $2.0k | 100% | Dec 2024 |
|
| Centerpoint Advisors | 350.00 | $999.985000 | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 314.00 | $1.1k | 77% | Dec 2024 |
|
| Wells Fargo & Company | 65.00 | $217.997000 | 0% | Dec 2024 |
|
| FMR | 5.00 | $17.000000 | 100% | Dec 2024 |
|
Who sold out of Vyne Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| AlphaCentric Advisors | Sep 2024 | 269k | $505k |
| ADAR1 Capital Management | Sep 2024 | 153k | $287k |
| Silverarc Capital Management | Sep 2024 | 77k | $144k |
| Lynx1 Capital Management | Sep 2024 | 16k | $30k |
| Russell Investments | Sep 2024 | 187.00 | $350.999000 |
| Barclays | Sep 2024 | 100.00 | $0 |